The Girl Who Defeated the World's Deadliest Virus

Editor’s Note
Dear readers,
Some stories feel like they belong in a thriller: an ordinary teen, a hidden bite, a virus that has killed for millennia, and one doctor who refused to accept the inevitable. Jeanna Giese’s survival isn’t just medical history,it’s a masterclass in courage, innovation, and the thin line between miracle and controversy. We dug deep into primary sources, peer-reviewed papers, and 2024 reflections to bring you the full, unvarnished narrative. Buckle up. This one lingers.

It was a crisp September evening in 2004 at St. Patrick’s Church in Fond du Lac, Wisconsin. Fifteen-year-old Jeanna Giese, an animal-loving athlete who played volleyball and softball, spotted a bat fluttering against a window. She gently picked it up to release it outside. In the struggle, the creature delivered a tiny 5-mm laceration to her left index finger—barely noticeable. Her parents washed the wound with peroxide. No one thought twice about rabies. Why would they? In the United States, bat bites are often dismissed as insignificant.

Thirty-seven days later, Jeanna’s world unraveled.

Rabies is one of humanity’s oldest documented terrors. Ancient Babylonian texts from the 23rd century BC describe the “mad dog disease.” Aristotle called it the “madness of dogs.” By the 16th century, Italian physicians labeled it an “incurable wound.” Louis Pasteur’s 1885 vaccine breakthrough—first tested on a nine-year-old boy mauled by a rabid dog—finally offered prevention. Yet once symptoms appear, the verdict remained unchanged for millennia: nearly 100% fatal.

Knowing when to retire is harder than knowing how much to save. The timing depends on what your retirement actually looks like: how long your money needs to last, what you'll spend, and where your income comes from.

When to Retire: A Quick and Easy Planning Guide is built for investors with $1,000,000 or more who are ready to move from saving to planning. Download your free guide and start working through the details.

Download your free guide.

Key facts today (WHO data):

Jeanna returned to school and sports after the bite. Then, in mid-October, subtle signs appeared: fatigue, tingling in her left hand, double vision, vomiting, unsteady gait. Within days she developed slurred speech, tremors, fever, and ataxia. By hospital admission at Children’s Wisconsin in Milwaukee, she was semi-obtunded, salivating uncontrollably, and required intubation.

CDC tests confirmed rabies antibodies in serum and cerebrospinal fluid. Virus isolation failed—typical for bat strains—but the diagnosis was unequivocal. Standard post-exposure prophylaxis was useless; symptoms had already begun. Doctors gave her parents the grim reality: hospice or certain death within days.

Jeanna’s parents chose aggressive care.

Pediatric infectious-disease specialist Dr. Rodney Willoughby Jr. proposed something never tried on a human: induce a deep therapeutic coma to “shut the brain down” while her immune system mounted a defense. The hypothesis was revolutionary—and risky. Rabies does not primarily destroy neurons through massive cell death; it disrupts neurotransmission (particularly GABA and serotonin pathways), causing fatal autonomic and respiratory failure. If the brain could be protected from over-excitation and the body supported, antibodies might clear the virus.

The protocol (later named the Milwaukee Protocol):

Every day, 4.5 million readers turn to 1440 for their factual news fix. We sift through 100+ sources to bring you a complete summary of politics, global events, business, and culture — all in a brief 5-minute email. No spin. No slant. Just clarity.

Join for free today!

Within eight days, rabies antibodies surged in her CSF. Sedation was tapered. By day 31 she was virus-free. She left the hospital on day 76. At five months post-admission, she was alert, communicative, though still dealing with choreoathetosis, dysarthria, and unsteady gait. Full recovery took years of physical and speech therapy.

Direct quote from Jeanna (2008): “They shouldn’t stop ’till it’s perfected.”

Jeanna became the first documented survivor of symptomatic rabies without prior vaccination. The protocol was attempted dozens of times worldwide. Dr. Willoughby has cited up to 18 survivors by 2018; by 2024, he referenced 18 of 45 total documented rabies survivors linked to the approach. Yet independent reviews tell a different story.

A 2025 paper in Clinical Infectious Diseases (“Demise of the Milwaukee Protocol”) analyzed 64+ documented failures. Critics argue the specific drug cocktail adds no proven benefit beyond aggressive critical care. Many “survivors” either had partial prior vaccination, received only supportive ICU care, or lacked full verification. Bat-variant rabies may simply allow a longer window for immune response than dog strains.

Tired of spin? The Flyover delivers fast, fact-focused news across politics, business, sports, and more — free every morning. No agenda. No paywall. Join 2.3 million readers who trust us to start their day right.

Start Reading for Free

Dr. Willoughby’s reflection (2024): “In all honesty, we were probably just pretty lucky.”
Jeanna’s 2024 take: “The road to recovery was very long and painful. I don’t quit. I guess it’s personal stubbornness.”

The ethical tension remains raw: Was it right to subject a 15-year-old to experimental coma, potential organ toxicity (Jeanna experienced hemolysis, acidosis, pancreatitis), and possible survival with severe disability? In resource-poor countries, such care is impossible—and critics ask whether prevention (dog vaccination, prompt PEP) should always trump heroic salvage.

Rabies remains a neglected tropical disease killing tens of thousands yearly despite being 100% preventable with timely vaccine. In the U.S., bat exposures cause nearly all human cases because bites are tiny and often unnoticed. Jeanna’s case proved symptomatic rabies is not inevitably fatal and spotlighted neuroprotective strategies now explored for other encephalitides.

Yet the protocol’s mixed legacy has shifted focus back to prevention and improved critical care. Newer research examines monoclonal antibodies and antivirals targeting viral replication earlier. Jeanna herself became an advocate, graduating college, marrying, and becoming a mother of three. She works at the Children’s Museum of Fond du Lac and still loves bats. “I always wanted to be a mom and now I am one and it’s just fantastic.”

Her survival underscores a timeless truth: sometimes the best weapon against a relentless killer is buying time—for the body, for science, for hope.

Twenty years later, Jeanna Giese stands as living proof that dogma can be rewritten by one doctor’s audacity and one patient’s resilience. The virus that has haunted humanity since antiquity met its match not in a miracle drug, but in a medically induced sleep that let the immune system do what it was built to do.

In an age of AI, CRISPR, and instant cures, her story is a humbling reminder: the frontier of medicine is still crossed by bold hypotheses, parental courage, and sheer stubborn refusal to accept “impossible.”

What would you do if told your child had hours to live? Jeanna’s family chose the unknown. The world is better for it.

What do you think—should experimental protocols like this be attempted again, or is prevention the only ethical path? Reply below or share this with someone who needs to believe in second chances.

Subscribe to Visionary Void for more deep-dive investigations that challenge what we think we know. Hit share if this story moved you—every new subscriber helps us uncover the next hidden chapter of human resilience.

Looking for more great writing in your inbox? Discover the other newsletters our audience loves to read-